Molecular Disease Characterization Initiative (MDCI)
NCT04772053
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class
Stopped
The study was terminated for reasons pertaining to feasibility
Conditions
Lung Cancer, Non-Small Cell
Neoplasms
Interventions
PROCEDURE:
Tumor biopsy
Sponsor
GlaxoSmithKline